329 results match your criteria: "centre Paul Broca[Affiliation]"
Proc Natl Acad Sci U S A
July 2006
Institut National de la Santé et de la Recherche Médicale, Unité de Neurobiologie et Pharmacologie Moléculaire, U573, Centre Paul Broca, 75014 Paris, France.
Familial essential tremor (ET), the most common inherited movement disorder, is generally transmitted as an autosomal dominant trait. A genome-wide scan for ET revealed one major locus on chromosome 3q13. Here, we report that the Ser9Gly variant in the dopamine D(3) receptor gene (DRD3), localized on 3q13.
View Article and Find Full Text PDFCNS Neurol Disord Drug Targets
February 2006
INSERM, Unité de Neurobiologie et Pharmacologie, Moléculaire (U573), Centre Paul Broca, 2ter rue d'Alésia, 75014 Paris, France.
The role of the D(3) receptor has remained largely elusive before the development of selective research tools, such as selective radioligands, antibodies, various highly specific pharmacological agents and knock-out mice. The data collected so far with these tools have removed some of the uncertainties regarding the functions mediated by the D(3) receptor. The D(3) receptor is an autoreceptor that controls the phasic, but not tonic activity of dopamine neurons.
View Article and Find Full Text PDFBr J Pharmacol
April 2006
INSERM, Unité de Neurobiologie et Pharmacologie Moléculaire (U573), Centre Paul Broca, 2 ter rue d'Alésia, 75014 Paris, France.
Various histamine derivatives were investigated at the human H3 receptor (H3R) and H4 receptor (H4R) stably expressed in human embryonic kidney (HEK)-293 cells using [125I]iodoproxyfan and [3H]histamine binding, respectively. In Tris buffer, [3H]histamine binding to membranes of HEK(hH4R) cells was monophasic (K(D) of 3.8+/-0.
View Article and Find Full Text PDFMed Sci (Paris)
December 2005
Inserm U.549, Centre Paul Broca, 2ter, rue d'Alésia, 75014, Paris, France.
FASEB J
November 2005
INSERM U 573, Centre Paul Broca, Paris, France.
When overexpressed, a short cytoplasmic domain of the amyloid precursor protein (APP), normally unmasked in the brain of Alzheimer's disease patients, activates caspase-3 and induces neuronal death. Death induction by this "Jcasp" domain is lost when tyrosine 653 is changed into an aspartate, suggesting specific interactions with unknown partners. To identify these putative partners and start to elucidate the mechanisms involved in Jcasp-induced cell death, we internalized a biotinylated version of the peptide into primary neurons and analyzed intracellular interacting proteins by pull-down and mass spectrometry.
View Article and Find Full Text PDFBiochem Biophys Res Commun
September 2005
INSERM U573, Centre Paul Broca, 2ter rue d'Alésia, 75014 Paris, France.
Modeling the three-dimensional structure of neprilysin 2 (NEP2) using the crystal structure of neprilysin as template revealed that their active sites share many common features, though slight differences therein cannot completely account for their specific pharmacological profiles. Recent evidence also suggest that residues outside the active site can play crucial functions in the maturation and enzymatic activity of these metalloproteases. To further explore the functions of amino acids in the acquisition and maintenance of the NEP2 structure, site-directed mutagenesis of conserved residues involved in the enzymatic activity of ECE-1 was performed.
View Article and Find Full Text PDFNeuroreport
August 2005
INSERM (E117), Centre Paul Broca, 75014 Paris, France.
One of the main features of schizophrenia is its age at onset in early adulthood. Dopaminergic dysregulation is the most documented neurobiological factor that may be involved in triggering schizophrenia. Recent findings on neurodevelopmental processes show that the brain-derived neurotrophic factor plays a critical role in the development of mesolimbic dopaminergic-related systems and regulates the expression of dopamine D3 receptors.
View Article and Find Full Text PDFInt J Neuropsychopharmacol
September 2005
INSERM U 573, Department of Neurobiology and Molecular Pharmacology, Centre Paul Broca, Paris, France.
Nat Genet
April 2005
Institut National de la Santé et de la Recherche Médicale, Avenir Group, Laboratory of Genomic Biology, Centre Paul Broca, 75014 Paris, France.
We report that Sir2 activation through increased sir-2.1 dosage or treatment with the sirtuin activator resveratrol specifically rescued early neuronal dysfunction phenotypes induced by mutant polyglutamines in transgenic Caenorhabditis elegans. These effects are dependent on daf-16 (Forkhead).
View Article and Find Full Text PDFJ Neurosci
February 2005
Institut National de la Santé et de la Recherche Médicale, U549, Centre Paul Broca, F-75014 Paris, France.
GABAergic septohippocampal neurons play a major role in the generation of hippocampal theta rhythm, but modulatory factors intervening in this function are poorly documented. The neuropeptide somatostatin (SST) may be one of these factors, because nearly all hippocampal GABAergic neurons projecting to the medial septum/diagonal band of Broca (MS-DB) express SST. In this study, we took advantage of the high and selective expression of the SST receptor sst2A in MS-DB to examine its possible role on theta-related activity.
View Article and Find Full Text PDFNeuroscience
April 2005
Laboratoire de Physiopathologie des Maladies Psychiatriques, Développement et Vulnérabilité, E0117 INSERM-Centre Paul Broca, 2 ter rue d'Alésia, 75014 Paris, France.
Despite consistent evidence of an association between depression and impaired memory performance, only a few studies have investigated memory processes in animal models of depression. The aim of the present study was to determine if rats selected for marked differences in their immobility response in the forced swimming test (FST, i.e.
View Article and Find Full Text PDFLife Sci
January 2005
Unité de Neurobiologie et Pharmacologie Moléculaire (INSERM U.573), Centre Paul Broca, 75014 Paris, France.
The dopamine D3 receptor (D3R) has been implicated in schizophrenia, drug addiction, depression and Parkinson's disease. The D3R is localized post-synaptically on nucleus accumbens neurons, but is also an autoreceptor on dopaminergic neurons in the mesencephalon. Its functional role as autoreceptor is highly debated, but supported by the elevated basal extracellular dopamine levels found in D3R-deficient mice.
View Article and Find Full Text PDFBioinformatics
April 2005
INSERM, Avenir Group, Laboratory of Genomic Biology, Centre Paul Broca, 75014 Paris, France.
Motivation: To identify genetic conservation relative to precise aspects of developmental diversity, an essential question in computational biology, we developed a new comparative method that allows conserved modules for the best balance between protein sequence similarity and gene co-expression to be constructed, in invertebrates.
Results: Our method, referred to as the best-balance constraint procedure (BBCP), yielded 719 functionally conserved modules (FCMs) comprising 2-23 gene pairs. These modules were consistent with the developmental roles of orthologues as inferred from Gene Ontology, RNAi knockouts, InterPro and process-specific microarray data.
Protein Pept Lett
October 2004
Unité de Neurobiologie et Pharmacologie Moléculaire (U573) de l'INSERM. Centre Paul Broca, 2ter rue d'Alésia, 75014 Paris, France.
Neprilysin 2 is a recently identified glycoprotein displaying the highest degree of sequence identity with neprilysin (EC 3.4.24.
View Article and Find Full Text PDFNeuroreport
October 2004
Unité de Neurobiologie et Pharmacologie Moléculaire (INSERM U 573), Centre Paul Broca, 75014 Paris, France.
The dopamine D3 receptor (DRD3) mediates expression of conditioned effects of psychostimulants, but conflicting results have been obtained with opiates. In a conditioned place preference (CPP) procedure, morphine increased the time spent in a compartment previously paired with drug injection. CPP was obtained at morphine doses of 16 and 32 mg/kg in wild-type (drd3+/+) mice and 8, 16 and 32 mg/kg in DRD3-knockout (drd3-/-) mice.
View Article and Find Full Text PDFMol Biol Cell
November 2004
Unité de Neurobiologie et Pharmacologie Moléculaire, Institut National de la Santé et de la Recherche Médicale, U 573, Centre Paul Broca, 75104 Paris, France.
Pleiotropic G proteins are essential for the action of hormones and neurotransmitters and are activated by stimulation of G protein-coupled receptors (GPCR), which initiates heterotrimer dissociation of the G protein, exchange of GDP for GTP on its Galpha subunit and activation of effector proteins. Regulator of G protein signaling (RGS) proteins regulate this cascade and can be recruited to the membrane upon GPCR activation. Direct functional interaction between RGS and GPCR has been hypothesized.
View Article and Find Full Text PDFJ Neurochem
September 2004
Unité de Neurobiologie et Pharmacologie Moléculaire (U573) de l'INSERM, Centre Paul Broca, Paris, France.
The existence of mouse H3-receptor isoforms was investigated by PCR analysis and cDNA cloning. Splicing mechanisms previously reported in various species are conserved in the mouse. The retention/deletion of a fragment in the third intracellular loop of the mouse receptor leads to the existence of three isoforms designated mH(3(445)), mH(3(413)) and mH(3(397)) according to the length of their deduced amino acid sequence.
View Article and Find Full Text PDFNeurotox Res
January 2005
INSERM E 0117, Physiopathologie des Maladies Psychiatriques, Centre Paul Broca, 2ter rue d'Alésia, 75014 Paris, France.
The direct hippocampal to prefrontal cortex pathway and its changes in synaptic plasticity is a useful framework for investigating the functional operations of hippocampal-prefrontal cortex communication in cognitive functions. Synapses on this pathway are modifiable and synaptic strength can be turned up or down depending on specific patterns of activity in the pathway. The objective of this review will be to summarize the different studies carried out on this topic including very recent data and to underline the importance of animal models for the development of new and effective medications in psychiatric diseases.
View Article and Find Full Text PDFJ Biol Chem
October 2004
Unité de Neurobiologie et Pharmacologie Moléculaire (INSERM U573), Centre Paul Broca, 2 ter rue d'Alésia, 75014 Paris, France.
Neprilysin 2 (NEP2), a recently identified member of the M13 subfamily of metalloproteases, shares the highest degree of homology with the prototypical member of the family neprilysin. Whereas the study of the in vitro enzymatic activity of NEP2 shows that it resembles that of NEP as it cleaves the same substrates often at the same amide bonds and binds the same inhibitory compounds albeit with different potencies, its physiological role remains elusive because of the lack of selective inhibitors. To aid in the design of these novel compounds and better understand the different inhibitory patterns of NEP and NEP2, the x-ray structure of NEP was used as a template to build a model of the NEP2 active site.
View Article and Find Full Text PDFNeurotox Res
August 2004
Unité de Neurobiologie et Pharmacologie Moléculaire, INSERM U 573, Centre Paul Broca, 2 ter rue d'Alésia, 75014 Paris, France.
Symptoms of schizophrenia are improved by dopamine antagonists and exacerbated by dopamine-releasing agents, suggesting hyperactivity of dopamine. However, chronic blockade of glutamate neurotransmission by antagonists at the N-methyl-D-aspartate (NMDA) receptor subtype produces a pathophysiological state resembling schizophrenia. A link between cortical glutamate/NMDA deficiency and subcortical dopamine hyperactivity, particularly in the mesolimbic pathway, has been hypothesized in schizophrenia.
View Article and Find Full Text PDFEur J Neurosci
May 2004
INSERM U549, IFR Broca-Sainte Anne, Centre Paul Broca, 2ter rue d'Alésia, 75014 Paris, France.
Increasing evidence suggests that somatostatin may control neuronal excitability during epileptogenesis. In the hippocampus, sst2A receptors are likely to mediate somatostatin inhibitory actions but little is known about their status in kindled tissues. In the present study, sst2A receptor and somatostatin immunoreactivity were examined by confocal microscopy in the hippocampus during and after kindling acquisition.
View Article and Find Full Text PDFJ Hypertens
April 2004
Institut National de la Santé et de la Recherche Médicale, Unit 573, Centre Paul-Broca, Paris, France.
Background: Endothelin-1 (ET-1) is a potent vasoactive peptide that has been implicated in the regulation of basal vascular tone. Endothelin-converting enzyme-1 (ECE-1), the main enzyme responsible for ET-1 generation, may contribute to blood pressure (BP) control. A possible association between a polymorphism of the gene encoding ECE-1 (ECE1B C-338A) and BP values in untreated hypertensive women was recently reported.
View Article and Find Full Text PDFJ Mol Neurosci
September 2004
Laboratory of Genomic Biology, Inserm Avenir Group, Centre Paul Broca, 75014 Paris, France.
The identification of disease genes for several neurodegenerative illnesses has allowed for the development of disease models in experimental organisms. We discuss our approach to studying Huntington's disease, the best characterized of the polyglutamine (polyQ) expansion disorders. We have developed a system in Caenorhabditis elegans to study the effects of (polyQ)-dependent neuronal dysfunction at the resolution of two neurons in screening for genetic and pharmacological suppression.
View Article and Find Full Text PDFPsychopharmacology (Berl)
September 2004
Unité de Neurobiologie et Pharmacologie Moléculaire (INSERM U 573), Centre Paul Broca, 2ter, rue d'Alésia, 75014 Paris, France.
Rationale: The dopamine D3 receptor has been shown to mediate conditioned effects of psychostimulants such as cocaine. The present work was aimed at determining whether drugs acting at D3 receptors alter acquisition of conditioned effects of opiates.
Methods: We have used the conditioned place preference (CPP) in mice, which permits the measurement of approach behaviour to environmental stimuli previously paired with drug effects.
Int Rev Neurobiol
May 2004
Unité de Neurobiologie et Pharmacologie Moléculaire, INSERM U 573, Centre Paul Broca, 75014 Paris, France.